NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Summit Therapeutics Inc. ("Summit" or "the Company") (NASDAQ:SMMT). Investors who purchased Summit securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SMMT. Investigation […]

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities prior to July 3, 2023, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barnes & Noble Education, Inc. ("Barnes & Noble" or "the Company") (NYSE:BNED). Investors who purchased Barnes & Noble securities are encouraged to obtain additional information and assist the investigation

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ:LFMD) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:SRPT). Investors who purchased Sarepta securities prior to June 22, 2022, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rocket Pharmaceuticals, Inc. ("Rocket" or "the Company") (NASDAQ:RCKT). Investors who purchased Rocket securities prior to September 17, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lamb Weston Holdings, Inc. ("Lamb Weston" or "the Company") (NYSE:LW). Investors who purchased Lamb Weston securities prior to July 25, 2023, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DoubleVerify Holdings, Inc. ("DoubleVerify" or "the Company") (NYSE:DV). Investors who purchased DoubleVerify securities prior to November 10, 2023, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Compass Diversified Holdings ("Compass" or "the Company") (NYSE:CODI). Investors who purchased Compass securities prior to March 1, 2023, and continue to hold to the present, are encouraged to obtain